# Phagenesis: Medical devices, Manchester, United Kingdom > Phagenesis: Phagenesis Ltd. is a UK-based medical technology company founded in 2007, focused on developing non-surgical neurostimulation therapies for... Source: https://millionrounds.com/startup/phagenesis (Millionrounds; every figure on the page links to its filing or article) United Kingdom · [Medical devices startup](https://millionrounds.com/companies) # Phagenesis Phagenesis Ltd. is a UK-based medical technology company founded in 2007, focused on developing non-surgical neurostimulation therapies for neurogenic dysphagia, particularly in pa Funding reported Last round: Series D Medical devices Manchester, United Kingdom Company summary - **Founded:** 2007 19 years old - **Team:** 79 51 to 200 people - **Funding reported:** 71.4M as listed, currency not stated - **Last round:** Series D Mar 2024 How sure we are - ✓ **Listed** We know it exists and what it does - 2 **Funding reported** A company dataset reports a raise - 3 **Observed** A filing or a dated announcement confirms a round No round for Phagenesis has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology) ## About Phagenesis Phagenesis Ltd. is a UK-based medical technology company founded in 2007, focused on developing non-surgical neurostimulation therapies for neurogenic dysphagia, particularly in pa tients recovering from stroke or neurological injuries. The company is headquartered in Manchester and operates as a subsidiary of Nestlé Health Science. Led by CEO Reinhard Krickl, Phagenesis employs around 47 people and is dedicated to improving patient recovery and reducing healthcare burdens. The core product, the Phagenyx® Neurostimulation System, is the first therapy to deliver targeted pharyngeal electrical stimulation to restore safe swallowing. This non-invasive device stimulates nerves in the pharynx, leveraging the brain's neuroplasticity to regain control of swallowing functions. Supported by over 20 years of research and extensive clinical evidence, the system enhances swallowing safety and efficiency, accelerates recovery from dysphagia, and integrates into care protocols for stroke rehabilitation and neurocritical care. Phagenesis primarily serves healthcare providers, including stroke rehabilitation centers and speech-language pathology clinics, aiming to improve outcomes for patients with swallowing impairments. ## What company datasets say Phagenesis raised Funding, as reported Reported in all **71.4M** in the source's currency Rounds **5** Last round **Series D** Last round size **12.7M** Last round date **Mar 2024** Investors listed **7** ## Funding filed with regulators Phagenesis filed 3 raises, $39M in all. Filings say how much was sold and to how many investors; they never name the investors. - Apr 2026 **$12M** UK share allotment - Aug 2025 **$13M** UK share allotment - Aug 2024 **$14M** UK share allotment ## Founders and team From Phagenesis's own website: 2 founders, 19 on the team. **Conor Mulrooney** Co-Founder & Chief Operating Officer **Shaheen Hamdy** Co-Founder & Chief Scientific Officer - **Andre Nel** Chief Financial Officer - **Marc Korenberg** Chief Financial Officer - **Anil Keni** VP Global Marketing - **Buck Weller** VP Sales, US - **Cari Manypenny** Head of Global Education - **Maddy Sadiq** Head of Human Resources - **Nick Woodcock** VP Sales, Europe - **Scott Grant** VP US Therapy Development - **Stephen Halstead** Head of QA/RA - **Boris Deutschmann** Director European Sales - **Chad Hoskins** Director - **Drew Burdon** Director - **Fred Edenius** Director - **Independent Advisor** Director - **James Gibbons** Director - **Michael Sjöström** Director - **Michel Gardet** Director - **Oern Stuge** Chairperson, Director And 1 more on the team. ## On 2 portfolio pages Investors who name them - [Aphelion Capital](https://millionrounds.com/fund/aphelion-capital) - [Scientific Venture Partners](https://millionrounds.com/fund/scientific-venture-partners) Each firm lists Phagenesis on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source. ## The company, in detail What they build Known for cortical reorganization non-surgical therapy brain injury recovery health care sensorimotor cortex medical device regulation neurostimulation distribution manufacturing long-term cortex reorganization real-world data dysphagia therapy personalized therapy neuroplasticity pharyngeal electrical stimulation neurostimulation in icu Built with from their website Salesforce CRM Analytics WP Engine Hubspot Barracuda MSP Microsoft Exchange Salesforce MySQL Microsoft 365 Apps & Services Greenhouse Fasthosts +8 more Anthropic Claude Barracuda Email Security Service Barracuda Networks Wordpress Microsoft Exchange Online Microsoft 365 Outlook PHP - **Sector:** Medical devices - **Industry code:** NAICS 33911, 334510, SIC 3844, 3841 - **Region:** England - **Part of:** Nestlé Health Science - **Revenue:** 4.3M a year, as listed - **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/phagenesis) ## Medical devices in United Kingdom Startups like it - [**CMR Surgical** Milton · founded 2014 *Raised*](https://millionrounds.com/company/cmr-surgical) - [**Brainomix** Oxford · founded 2010 *Raised*](https://millionrounds.com/company/brainomix) - [**Axial3D** Belfast · founded 2014 *Raised*](https://millionrounds.com/company/axial3d) - [**Feebris** London · founded 2019 *Raised*](https://millionrounds.com/company/feebris) - [**Optellum** Oxford · founded 2016 *Raised*](https://millionrounds.com/company/optellum) - [**Quanta Dialysis Technologies** Warwick · founded 2008](https://millionrounds.com/startup/quanta-dialysis-technologies) - [**Osler Diagnostics** Oxford · founded 2017](https://millionrounds.com/startup/osler-diagnostics) - [**OrganOx** Oxford · founded 2008](https://millionrounds.com/startup/organox) ## Is this your company? Add your raise, your deck and your story, and put Phagenesis in front of investors. Or tell us what we have wrong. [List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)